p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53

Molecular Cloning: A Laboratory Manual

Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589

Molecular cloning: A laboratory manual

Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684

WAF1, a potential mediator of p53 tumor suppression

El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651

Participation of p53 protein in the cellular response to DNA damage.

Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761

p21 is a universal inhibitor of cyclin kinases

Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691

The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product

Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803

Universal control mechanism regulating onset of M-phase

Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798

Regulation of the G2/M transition by p53

Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,584

Census and evaluation of p53 target genes

Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971

Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53

Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 811

Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

Engeland, K. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.172 · Cited by 679

p53 and E2f: partners in life and death

Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498

Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression

Godár, S., Ince, T. A., Bell, G. W., Feldser, D. M., Donaher, J. L., Bergh, J. C. S., Liu, A. Y., Miu, K., Watnick, R. S., Reinhardt, F., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.006 · Cited by 455

Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks

Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330

The common and distinct target genes of the p53 family transcription factors

Harms, K. L., Nozell, S. E., & Chen, X. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3304-4 · Cited by 303

Control of the G2/M Transition

Stark, G. R., & Taylor, W. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:32:3:227 · Cited by 282

Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.

Fischer, M., & Müller, G. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1360836 · Cited by 255

p21/CDKN1A Mediates Negative Regulation of Transcription by p53

Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227

CDC20, a potential cancer therapeutic target, is negatively regulated by p53

Kidokoro, T., Tanikawa, C., Furukawa, Y., Katagiri, T., Nakamura, Y., & Matsuda, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210799 · Cited by 206

Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters

Imbriano, C., Gurtner, A., Cocchiarella, F., Agostino, S. D., Basile, V., Gostissa, M., Dobbelstein, M., Sal, G. D., Piaggio, G., & Mantovani, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3737-3751.2005 · Cited by 209

Analyzing the G2/M Checkpoint

Stark, G. R., & Taylor, W. R. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:051 · Cited by 203

Pro-proliferative FoxM1 is a target of p53-mediated repression

Barsotti, A. M., & Prives, C. L. (2009) · Oncogene · doi:10.1038/onc.2009.282 · Cited by 163

The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3

Zhang, J., Yang, J., Roy, S. K., Tininini, S., Hu, J., Bromberg, J., Poli, V., Stark, G. R., & Kalvakolanu, D. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633516100 · Cited by 167

DNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms

Clair, S. S., Giono, L. E., Varmeh, S., Resnick‐Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 168

Aberrant Regulation of Survivin by the RB/E2F Family of Proteins

Jiang, Y., Saavedra, H. I., Holloway, M. P., Leone, G. W., & Altura, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404496200 · Cited by 159

The transcription factor p53: Not a repressor, solely an activator.

Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153

Dynamic Recruitment of NF-Y and Histone Acetyltransferases on Cell-cycle Promoters

Caretti, G., Salsi, V., Vecchi, C., Imbriano, C., & Mantovani, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304606200 · Cited by 153

Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts

Baus, F., Gire, V., Fisher, D., Piette, J., & Dulić, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg387 · Cited by 143

Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1

Göke, R., Barth, P. J., Schmidt, A., Samans, B., & Lankat–Buttgereit, B. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00025.2004 · Cited by 137

p53-dependent Down-regulation of Telomerase Is Mediated by p21

Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402502200 · Cited by 133

Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung Cancer

Tong, X., Xie, D., O'Kelly, J., Miller, C. W., Muller-Tidow, C., & Koeffler, H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107878200 · Cited by 132

Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression

Spurgers, K. B., Gold, D. L., Coombes, K. R., Bohnenstiehl, N. L., Mullins, B., Meyn, R. E., Logothetis, C. J., & McDonnell, T. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513901200 · Cited by 114

Distinct mechanisms act in concert to mediate cell cycle arrest

Toettcher, J. E., Loewer, A., Ostheimer, G. J., Yaffe, M. B., Tidor, B., & Lahav, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806196106 · Cited by 112

G2 arrest in response to topoisomerase II inhibitors: the role of p53.

Clifford, B., Beljin, M., Stark, G. R., & Taylor, W. R. (2003) · PubMed · Cited by 109

Primary and Compensatory Roles for RB Family Members at Cell Cycle Gene Promoters That Are Deacetylated and Downregulated in Doxorubicin-Induced Senescence of Breast Cancer Cells

Jackson, J. G., & Pereira-Smith, O. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2501-2510.2006 · Cited by 108

Cell cycle molecules and vertebrate neuron death: E2F at the hub

Greene, L. A., Biswas, S. C., & Liu, D. X. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401341 · Cited by 108

Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA

Huang, Y., Liu, N., Liu, J., Liu, Y., Zhang, C., Long, S., Luo, G., Zhang, L., & Zhang, Y. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1688951 · Cited by 94

p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2

Jackson, M. W., Agarwal, M. K., Yang, J., Bruss, P., Uchiumi, T., Agarwal, M. L., Stark, G. R., & Taylor (2005) · Journal of Cell Science · doi:10.1242/jcs.02307 · Cited by 92

p53 is a NF‐Y‐ and p21‐independent, Sp1‐dependent repressor of cyclin B1 transcription

Innocente, S. A., & Lee, J. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.073 · Cited by 86

p53 Promotes Cell Survival due to the Reversibility of Its Cell-Cycle Checkpoints

Lukin, D. J., Carvajal, L. A., Liu, W.-J., Resnick‐Silverman, L., & Manfredi, J. J. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0177 · Cited by 86

B-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells

Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82

Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients

Voghel, G., Thorin‐Trescases, N., Farhat, N., Mamarbachi, A. M., Villeneuve, L. R., Fortier, A., Perrault, L. P., Carrier, M., & Thorin, É. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.01.004 · Cited by 83

Rb/E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression

Yang, J., Song, K. W., Krebs, T. L., Jackson, M. W., & Danielpour, D. (2008) · Oncogene · doi:10.1038/onc.2008.165 · Cited by 76

DNA Damage Promotes Histone Deacetylase 4 Nuclear Localization and Repression of G2/M Promoters, via p53 C-terminal Lysines

Basile, V., Mantovani, R., & Imbriano, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507712200 · Cited by 77

5‐ D emethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G 2/M cell cycle arrest and apoptosis

Charoensinphon, N., Qiu, P., Dong, P., Zheng, J., Ngauv, P., Cao, Y., Li, S., Ho, C., & Xiao, H. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300136 · Cited by 72

Wild-type p53 and p73 negatively regulate expression of proliferation related genes

Scian, M. J., Carchman, E. H., Mohanraj, L., Stagliano, K. E., Anderson, M. A. E., Deb, D., Crane, B., Kiyono, T., Windle, B. E., Deb, S., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210898 · Cited by 73

E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress

Polager, S., & Ginsberg, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210327200 · Cited by 70

Cdc2: A monopotent or pluripotent CDK?

Hu, X., & Moscinski, L. C. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00753.x · Cited by 69

p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers

Zhang, D. W., Jeang, K.-T., & Lee, C. G. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209220 · Cited by 70

Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53

Calvisi, D. F., Simile, M. M., Ladu, S., Frau, M., Evert, M., Tomasi, M. L., Demartis, M. I., Daino, L., Seddaiu, M. A., Brozzetti, S., et al. (2011) · Hepatology · doi:10.1002/hep.24174 · Cited by 65

Apoptosis repressor with caspase recruitment domain (ARC) is expressed in cancer cells and localizes to nuclei

Wang, M., Qanungo, S., Crow, M. T., Watanabe, M., & Nieminen, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.040 · Cited by 63

E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma

Crosby, M. E., Jacobberger, J. W., Gupta, D., Macklis, R. M., & Almasan, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209998 · Cited by 60

One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor

Böhlig, L., & Rother, K. (2011) · BioMed Research International · doi:10.1155/2011/464916 · Cited by 58

Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression

Bhawe, K. M., & Roy, D. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0395-3 · Cited by 55

Gene expression profiles in human cells submitted to genotoxic stress

Sakamoto‐Hojo, E. T., Mello, S. S., Pereira, E. C., Fachin, A. L., Cardoso, R. S., Junta, C. M., Sandrin‐Garcia, P., Donadi, E. A., & Passos, G. A. S. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.07.004 · Cited by 55

Cloning and characterization of a novel gene PDRG that is differentially regulated by p53 and ultraviolet radiation

Luo, X., Huang, Y., & Sheikh, M. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207010 · Cited by 55

Inhibitory Effects of Metabolites of 5-Demethylnobiletin on Human Nonsmall Cell Lung Cancer Cells

Song, M., Charoensinphon, N., Wu, X., Zheng, J., Gao, Z., Xu, F., Wang, M., & Xiao, H. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b01367 · Cited by 50

A role for p53 in terminal epithelial cell differentiation

Saifudeen, Z. R., Dipp, S., & El-Dahr, S. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13972 · Cited by 53

The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression

Fenouille, N., Robert, G., Tichet, M., Puissant, A., Dufies, M., Rocchi, S., Ortonne, J. P., Deckert, M., Ballotti, R., & Tartare‐Deckert, S. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00790.x · Cited by 47

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

Noll, J. E., Vandyke, K., Hewett, D. R., Mrozik, K. M., Bala, R. J., Williams, S. A., Kok, C. H., & Zannettino, A. C. W. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0209-2 · Cited by 43

Transcriptional Repression of Taurine Transporter Gene (TauT) by p53 in Renal Cells

Han, X., Patters, A. B., & Chesney, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205939200 · Cited by 43

The Epithelial Cell Transforming Sequence 2, a Guanine Nucleotide Exchange Factor for Rho GTPases, Is Repressed by p53 via Protein Methyltransferases and Is Required for G1-S Transition

Scoumanne, A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0121 · Cited by 42

Coordination of Repair, Checkpoint, and Cell Death Responses to DNA Damage

Wang, J. Y. J., & Cho, S. K. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)69004-8 · Cited by 43

The human 1‐8D gene (IFITM2) is a novel p53 independent pro‐apoptotic gene

Daniel‐Carmi, V., Makovitzki‐Avraham, E., Reuven, E. M., Goldstein, I., Zilkha, N., Rotter, V., Tzehoval, E., & Eisenbach, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24669 · Cited by 41

A Role for the Fanconi Anemia C Protein in Maintaining the DNA Damage-induced G2 Checkpoint

Freie, B. W., Ciccone, S. L. M., Li, X., Plett, P. A., Orschell, C. M., Srour, E. F., Hanenberg, H., Schindler, D., Lee, S., & Clapp, D. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407160200 · Cited by 40

The chemopreventive effect of 5-demethylnobiletin, a unique citrus flavonoid, on colitis-driven colorectal carcinogenesis in mice is associated with its colonic metabolites

Song, M., Lan, Y., Wu, X., Han, Y., Wang, M., Zheng, J., Li, Z., Li, F., Zhou, J., Xiao, J., et al. (2020) · Food & Function · doi:10.1039/d0fo00616e · Cited by 38

p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription

Tophkhane, C., Yang, S., Jiang, Y., Ma, Z., Subramaniam, D., Anant, S., Yogosawa, S., Sakai, T., Liu, W., Edgerton, S. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043564 · Cited by 37

E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53

Bajaj, S., Alam, S. K., Roy, K. S., Datta, A., Nath, S., & Roychoudhury, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731398 · Cited by 35

Ca 2+ /calmodulin‐dependent protein kinase II‐γ (CaMKIIγ) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling

Saddouk, F. Z., Sun, L., Liu, Y. F., Jiang, M., Singer, D. V., Backs, J., Riper, D. A. V., Ginnan, R. G., Schwarz, J. J., & Singer, H. A. (2015) · The FASEB Journal · doi:10.1096/fj.15-279158 · Cited by 33

Studies on radiation-induced apoptosis in G 0 human lymphocytes

Belloni, P., Meschini, R., Czene, S., Harms‐Ringdahl, M., & Palitti, F. (2005) · International Journal of Radiation Biology · doi:10.1080/09553000500303690 · Cited by 31

Transcriptional control of the proliferation cluster by the tumor suppressor p53

Brosh, R., & Rotter, V. (2009) · Molecular BioSystems · doi:10.1039/b911416e · Cited by 31

Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells

Wong, S. H. K., Shih, R. S. M., Schoene, N. W., & Lei, K. Y. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00061.2008 · Cited by 30

Improving the selectivity of cancer treatments by interfering with cell response pathways

Damia, G. L. M., & Broggini, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.020 · Cited by 28

p53-Mediated Growth Suppression in Response to Nutlin-3 in Cyclin D1–Transformed Cells Occurs Independently of p21

Kan, C. E., Patton, J. T., Stark, G. R., & Jackson, M. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0259 · Cited by 26

Role of p21 in SP600125-induced cell cycle arrest, endoreduplication, and apoptosis

Moon, D., Choi, Y. H., & Kim, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0626-5 · Cited by 26

Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor

Moxley, A. H., & Reisman, D. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3590 · Cited by 25

Exit from Arsenite-Induced Mitotic Arrest Is p53 Dependent

McNeely, S., Xu, X., Taylor, B. F., Zacharias, W., McCabe, M. J., & States, J. C. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8969 · Cited by 23

X‐irradiated human lymphocytes with unstable aberrations and their preferential elimination by p53/survivin‐dependent apoptosis

Bassi, L., Carloni, M., Meschini, R., Fonti, E., & Palitti, F. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001632930 · Cited by 23

Regulation of p53-dependent transcription

Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 20

Interplay between HMGA and TP53 in cell cycle control along tumor progression

Costa, N. M. D., Palumbo, A., Martino, M. D., Fusco, A., Pinto, L. F. R., & Nasciutti, L. E. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03634-4 · Cited by 20

Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G2–M arrest in A549 cells

Ikeda, M., Okamoto, I., Tamura, K., Satoh, T., Yonesaka, K., Fukuoka, M., & Nakagawa, K. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.08.005 · Cited by 15

p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.

Brusa, G., Benvenuti, M., Mazzacurati, L., Mancini, M., Pattacini, L., Martinelli, G., Barbieri, E., Greenberger, J. S., Baccarani, M., & Santucci, M. A. (2003) · PubMed · Cited by 14

Functional Analysis of CDK Inhibitor p21WAF1

Fotedar, R., Bendjennat, M., & Fotedar, A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-811-0:055 · Cited by 13

G2-phase arrest through p21(WAF1 / Cip1) induction and cdc2 repression by gnidimacrin in human hepatoma HLE cells.

Yoshida, M., Matsui, Y., Iizuka, A., & Ikarashi, Y. (2009) · PubMed · Cited by 12

P130 and its truncated form mediate p53-induced cell cycle arrest inRb−/− Saos2 cells

Gao, C.-F., Ren, S., Wang, J., Zhang, S.-L., Jin, F., Nakajima, T., Ikeda, M., & Tsuchida, N. (2002) · Oncogene · doi:10.1038/sj.onc.1205933 · Cited by 12

A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities

Rakotopare, J., Lejour, V., Duval, C. J., Eldawra, E., Escoffier, H., & Toledo, F. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050376 · Cited by 15

Nitric Oxide Down-regulates Polo-like Kinase 1 through a Proximal Promoter Cell Cycle Gene Homology Region

Zhang, J., Wang, S., Kern, S. J., Cui, X., & Danner, R. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607609200 · Cited by 11

ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2

Ma, X., Fan, M., Yang, K., Wang, Y., Hu, R., Guan, M., Hou, Y., Ying, J., Deng, N., Li, Q., et al. (2023) · Cancer Science · doi:10.1111/cas.15947 · Cited by 9

Targeting the Cell Cycle to Kill Cancer Cells

Taylor, W. R., & Grabovich, A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369521-5.00017-8 · Cited by 9

DNA synthesis inhibition in response to benzo[a]pyrene dihydrodiol epoxide is associated with attenuation of p34cdc2: Role of p53

Mukherjee, J. J., & Kumar, S. (2013) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.05.009 · Cited by 8

Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients

Vikhanskaya, F., & Broggini, M. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)19013-9 · Cited by 8

Identification and Mechanistic Studies of a Cell Cycle Regulator JP18 from a Library of Synthetic Indole Terpenoid Mimics

Pei, J., Zhou, S., Yang, F., Sun, Y., Li, A., Zhang, W., & He, W. (2016) · Chemistry - An Asian Journal · doi:10.1002/asia.201600714 · Cited by 7

A role for p53 in terminal epithelial cell differentiation

Saifudeen, Z. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200213972 · Cited by 7

Characterization of the CDP-like/CTAS-1 binding site in the okadaic acid response element (OARE) of the human CDK1(p34cdc2) promoter.

Bird, R. C., & DeInnocentes, P. (2004) · PubMed · Cited by 6

2‐Chloroethyl‐3‐sarcosinamide‐1‐nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53‐dependent and p53‐independent pathways

Huynh, H. T., Nguyen, T., Panasci, L., & Do, P. (2004) · Cancer · doi:10.1002/cncr.20670 · Cited by 5

Mechanisms of G2 Phase Arrest in DNA Damage-Induced Checkpoint Response

Kuang, J., & Wang, R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_3 · Cited by 3

Transactivation of Human cdc2 Promoter by Adenovirus E1A

Padmanabhan, R., Tanimoto, A., & Sasaguri, Y. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05597-7_12 · Cited by 2

SarCNU‐induced G2/M arrest in hepatoma cells is mediated by a p53‐independent phosphorylation of cdc‐2 at Tyr15

Hung, H., Chow, P. K. H., Soo, K. C., Panasci, L. C., & Hung, N. T. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20336 · Cited by 2

Research progress on cell cycle arrest in dermal fibroblasts

Wu, M., Luo, J., Yang, W., Wei, Z., Li, Y., & Pan, X. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2557240 · Cited by 1

RNA-Seq Uncovers Association of Endocrine-Disrupting Chemicals with Hub Genes and Transcription Factors in Aggressive Prostate Cancer

Alwadi, D., Felty, Q. H., Doke, M., Roy, D., Yoo, C., & Deoraj, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125463 · Cited by 1

Treatment-Induced Tumor Cell Senescence and Its Consequences

Broude, E. V. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-15 · Cited by 1

Vaccinia virus modulates the host cell cycle to promote infection

Martin, C. K. (2019) · UCL Discovery (University College London) · Cited by 1

NRF1 Transcriptomic Signatures Contribute to the Pathogenesis of the Most Aggressive Brain Cancer - Glioblastoma

Bhawe, K. M. (2021) · doi:10.25148/etd.fidc009549 · Cited by 1

G2 Phase Cell Cycle Regulation by E2F4 Following Genotoxic Stress

Crosby, M. E. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1

Signaling in natural killer cells: SHIP, 2B4 and the Kinome

Wahle, J. A. (2007) · Digital Commons - University of South Florida (University of South Florida)

The Cytolethal Distending Toxin of Actinobacillus actinomycetemcomitans Activates p53-dependent DNA Damage Checkpoint Pathways in Normal Human Fibroblasts

Morisaki, H., Kurihara, K., Haseba, Y., Takahashi, M., & Igarashi, T. (2005) · Shōwa Shigakkai zasshi/Showa Shigakkai zasshi · doi:10.11516/dentalmedres1981.25.161

Negative regulation of gene expression by the tumor suppressor p53

Barsotti, A. M. (2011) · doi:10.7916/d8mg7wkg

The Dual Specificity Phosphatase Cdc25C is a Direct Target for Transcriptional Repression by the Tumor Suppressor p53

Clair, S. S., & Manfredi, J. J. (2006) · Cell Cycle · doi:10.4161/cc.5.7.2628 · Cited by 39

p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes

Benson, E. K., Mungamuri, S. K., Attie, O., Kracikova, M., Sachidanandam, R., Manfredi, J. J., & Aaronson, S. A. (2013) · Oncogene · doi:10.1038/onc.2013.378 · Cited by 100

p53 can repress transcription of cell cycle genes through a p21WAF1/CIP1-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements

Quaas, M., Müller, G. A., & Engeland, K. (2012) · Cell Cycle · doi:10.4161/cc.22917 · Cited by 107

p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor

Yun, J., Chae, H., Choy, H. E., Chung, J., Yoo, H., Han, M.-H., & Shin, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29677 · Cited by 155

Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex

Fischer, M., Quaas, M., Nickel, A., & Engeland, K. (2015) · Oncotarget · doi:10.18632/oncotarget.6356 · Cited by 60